London stock exchange
Stocks and Finance

Shire

Shire 06/02/2012

17:58 : Vodafone rises as it calls off Greek merger, while Shire climbs on bid ... - Vodafone terminates plans to link up with Greece's Wind Hellas; Shire subject of renewed speculationMuch of the recent interest in Vodafone's overseas businesses has revolved around India, but on Monday the focus switched to Greece.In ...
Source : guardian-co-uk

Shire 30/01/2012

11:09 : Market seeks shelter in defensive stocks ahead of EU summit - Drugmakers and Vodafone rise as investors seek out defensive stocksPharmaceutical companies GlaxoSmithKline, AstraZeneca and Shire, along with telecoms giant Vodafone were in demand this morning as ...
Source : guardian-co-uk

Shire 24/01/2012

15:21 : Shire rival Genzyme gets US approval for treatment for Fabry disease - Following manufacturing problems, Genzyme gets the go-ahead to make competitor to Shire's ReplagalShire has shaken off news of US approval for a rival to one of its key drugs.The company's Replagal treatment for Fabry disease had seen a boost to its ...
Source : guardian-co-uk

Shire 18/01/2012

12:35 : Shire slips as rivals production problems look set to ease - Shire's treatment for Fabry disease benefited from Genzyme's troubles, but boom may be overShire has come under pressure on a renewed competitive threat to one of its key drugs.Its Replagal treatment for Fabry disease has seen a boost to its sales following ...
Source : guardian-co-uk

Shire 29/10/2011

21:48 : THE INTERVIEW: How fast-moving Shire has outsmarted the giants in pharmaceu - For Angus Russell, chief executive of pharmaceuticals group Shire, last week's third-quarter results continued what has been stellar growth in recent years. Delivering ever-rising profits, Britain's third-biggest drugs producer's share price ...

Shire 14/07/2011

19:13 : Shire hits a 'high' on hyperactivity drug hopes - Although the market slouched back into the doldrums amid jitters over America's credit rating, investors rushed into Shire, sending the pharmaceutical company to an all-time high.
Source : telegraph-co-uk

Shire 11/07/2011

22:10 : MARKET REPORT: Shire soars on dose of bid talk - Hyperactive punters dosed up with shares of Shire as revived takeover rumours swept dealing rooms. The UK's third-largest drugs group closed 22p up at a 52-week peak of 2002p on hefty turnover of 36m.

Shire 25/05/2011

16:34 : Banks lead FTSE 100 higher but Shire slips on competition concerns - Shire is facing a growing number of challenges to one of its best selling drugs, sending its shares lower in a rising market.The pharmaceutical group slipped 16p to £18.75 following news that rivals Amneal Pharmaceuticals and Watson Laboratories ...
Source : guardian-co-uk

Shire 20/05/2011

05:46 : AstraZeneca rumoured to be eyeing up US target - While the rumour mill has been rife with suggestions that AstraZeneca could make a tilt at its British peer Shire, there was speculation yesterday that Astra could be eyeing up an acquisition on the other ...
Source : telegraph-co-uk

Shire 19/05/2011

20:04 : Astra rumoured to be eyeing up US target - While the rumour mill has been rife with suggestions that AstraZeneca could make a tilt at its British peer, Shire, there was speculation on Thursday that Astra could be eyeing up an acquisition on the ...
Source : telegraph-co-uk

Shire 18/05/2011

19:05 : Shire stages turnaround on latest deal - Having helped keep the market on its sickbed earlier in the week, drug makers on Wednesday helped the large-caps stage a recovery as Shire shrugged off early scepticism about its latest acquisition.
Source : telegraph-co-uk
10:22 : Shire slips after $750m US wound healing deal - Shire shares have fallen back after the pharmaceutical group announced a $750m cash acquisition in America.It is buying privately owned Advanced BioHealing, which makes a bio-engineered skin substitute used to treat slow healing foot ulcers. ...
Source : guardian-co-uk
10:14 : Shire buys Advanced BioHealing for $750m - Shire agrees to buy US-based Advanced BioHealing to gain access to Dermagraft, a skin substitute that assists in restoring damaged tissue, for $750m (£462m) in cash
Source : ft-com

Shire 28/04/2011

18:37 : AstraZeneca, Shire decline in London trade - Equities markets in London were higher Thursday, as the FTSE 100 added 0.03 percent to 6,069.9 and the FTSE 250 gained 1 percent to 12,013.9 as the media sector and insurers saw gains, and most utilities were higher but banks were ...

Shire 10/02/2011

19:03 : Drug maker Shire sets new sales record - Shire's product sales broke the $3bn barrier for the first time last year as the drug maker benefited from manufacturing problems at a US rival and increased sales of its hyperactivity medicine.
Source : telegraph-co-uk
actualidad Shire -


Copyright © 2009 Finaperf.com - Bourse - Börse - Day trading - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts